August 26 2018
Translating our knowledge to the public
Our article in Now.com (Life) – 〈好Heal〉拆解癌症迷思
Part of the article shown below.
Full version can be found here.

August 26 2018
Translating our knowledge to the public
Our article in Now.com (Life) – 〈好Heal〉拆解癌症迷思
Part of the article shown below.
Full version can be found here.

August 14-18 2018 – Cold Spring Harbor Lab Meeting – Mechanisms and Models of Cancer.
Great meeting! Stephanie shared the team’s work ‘Arginine methylation by PRMT6 as a novel stemness and metabolic regulator in hepatocellular carcinoma”. Bonus: meeting James Watson! #watsonandcrick #thedoublehelix #nobellaureate #DNA #90yo
Some time ago, our team developed a monoclonal antibody specific against ANXA3. We are happy to share that after years of work, we have successfully obtained two US patents for the use of this antibody for HCC detection, prognosis and therapy (US 9,487,831 granted November 2016 and US 10,000,558 granted June 2018). Congrats to the 3 inventors on the patents – Stephanie Ma, Man Tong and Xin-Yuan Guan!
Stephanie is super happy to have had the opportunity to participate in the Croucher Science Week – What’s it like Being a Scientist? School Tours this year. She, along with her partner Krates, performed at the HK Science Museum during HK SciFest 2018 and at a number of local primary schools from March to November, spreading science fun.
Details to the show:
Science is fascinating. It brings wonder and understanding to the world. But, what is it like to be a scientist? In this entertaining show, you’ll meet scientists who will re-enact one of the greatest scientific experiments of all time – Galileo’s Leaning Tower of Pisa experiment. They will let you in on what it feels like to be a scientist doing cutting-edge research in modern day Hong Kong – and will lead the entire audience in a scientific experiment that everyone can do.
Our work on the role of ANXA3 in sorafenib resistance is now published in the Journal of Hepatology. Congrats to Carol and the team!
Tong M, Che N, Zhou L, Luk ST, Kau PW, Chai S, Ngan ES, Lo CM, Man K, Ding J, Lee TK, Ma S. Efficacy of antibody-mediated annexin A3 blockade in sensitizing hepatocellular carcinoma to sorafenib and regorafenib treatment. J Hepatol 2018; Epub ahead of print.
https://www.journal-of-hepatology.eu/article/S0168-8278(18)32119-6/fulltext